Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525446 · ClinicalTrials.gov registry record · Early Phase 1
Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
A Early Phase 1 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT01525446: Clinical Trial Early Phase 1 study, sponsored by Massachusetts General Hospital.
NCT01525446 is a Early Phase 1 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01525446, a Early Phase 1 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Stereotactic body radiation therapy (SBRT) is a special form of treatment which pinpoints high doses of radiation directly to cancer. Standard radiation (or photon radiation) is commonly used for SBRT to treat Non-Small Cell Lung Cancer (NSCLC). Proton beam radiation is a special type of radiation only available at a few institutions in the US and has not been previously used in SBRT to treat NSCLC. The use of protons for SBRT may improve the accuracy of the treatment and may help to minimize the dose delivered unnecessarily to healthy tissue. In this study, the investigators are evaluating the safety and effectiveness of proton-based SBRT for early-stage NSCLC located in the periphery of the lung.
Interventions
- RADIATION SBRT with proton beam radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01525446
The ClinicalTrials.gov registry entry for NCT01525446 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SBRT with proton beam radiation is the first listed.
NCT01525446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01525446 about?
NCT01525446 is a clinical study titled "Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer". Stereotactic body radiation therapy (SBRT) is a special form of treatment which pinpoints high doses of radiation directly to cancer. Standard radiation (or photon radiation) is commonly used for SBRT to treat Non-Small Cell Lung Cancer (NSCLC). Proton beam radiation is a special type of radiation o...
What is the current status of trial NCT01525446?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2011-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01525446?
The interventions under investigation include: SBRT with proton beam radiation (RADIATION).
Who is sponsoring clinical trial NCT01525446?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.